Loading tape…Loading tape…
VRTX
VRTX
VRTX
VRTX NASDAQ
Vertex Pharmaceuticals Inc ($VRTX) is highlighted following news that Ancora Advisors LLC acquired 1,127 shares. The company currently holds a market capitalization of $138.61 billion, supported by a fiscal year revenue of $12.07 billion. Additionally, the stock trades at a price-to-earnings ratio of 31.53, with a trailing twelve months EPS of 17.35 and a free cash flow yield of 2.74%.
Based on defenseworld.netAncora Advisors LLC Acquires Shares of 1,127 Vertex Pharmaceuticals Incorporated $VRTX
17,047 Shares in Vertex Pharmaceuticals Incorporated $VRTX Acquired by Beacon Pointe Advisors LLC
Breakfast News: Nvidia Crushed It. Who Cares?
Vertex to Participate in Upcoming September Investor Conferences
EP Wealth Advisors LLC Acquires New Position in Vertex Pharmaceuticals Incorporated $VRTX
Advisors Capital Management LLC Buys Shares of 1,258 Vertex Pharmaceuticals Incorporated $VRTX
Revenue & Net Income (5Y)
EPS & Growth (5Y)
Free Cash Flow (5Y)
Capital Returns
Operating & Net Margin (5Y)
CapEx vs. Free Cash Flow (5Y)
Capital Allocation (5Y)
R&D and SG&A Intensity (5Y)
EBITDA (5Y)
Cost of Revenue (5Y)
Market Cap (5Y)
Ask Stonks with professional market data, charts beside chat, and your portfolio context.
Tape shows delayed public market data. Not investment advice.